Evidence map›Paper›PMID 27090057›Full record

ArticleStatistics in medicine2016

Estimating the prevalence of multiple diseases from two-stage hierarchical pooling.

Md S Warasi, Joshua M Tebbs, Christopher S McMahan, Christopher R Bilder

Abstract read
In one paragraph

Article in Statistics in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Youden index estimation based on group-tested data.Statistical methods in medical research · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Md S WarasiDepartment of Statistics, University of South Carolina, Columbia, 29208, SC, U.S.A.
Joshua M TebbsDepartment of Statistics, University of South Carolina, Columbia, 29208, SC, U.S.A.
Christopher S McMahanDepartment of Mathematical Sciences, Clemson University, Clemson, 29634, SC, U.S.A.
Christopher R BilderDepartment of Statistics, University of Nebraska-Lincoln, Lincoln, 68583, NE, U.S.A.

Funding

Group testing for infectious disease detection: multiplex assays and back-end screeningR01AI121351 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI BILDER, CHRISTOPHER R · 2016 to 2025
$3.3M
NIAID NIH HHS R01 AI121351
6 · The paper itself

Abstract

Testing protocols in large-scale sexually transmitted disease screening applications often involve pooling biospecimens (e.g., blood, urine, and swabs) to lower costs and to increase the number of individuals who can be tested. With the recent development of assays that detect multiple diseases, it is now common to test biospecimen pools for multiple infections simultaneously. Recent work has developed an expectation-maximization algorithm to estimate the prevalence of two infections using a two-stage, Dorfman-type testing algorithm motivated by current screening practices for chlamydia and gonorrhea in the USA. In this article, we have the same goal but instead take a more flexible Bayesian approach. Doing so allows us to incorporate information about assay uncertainty during the testing process, which involves testing both pools and individuals, and also to update information as individuals are tested. Overall, our approach provides reliable inference for disease probabilities and accurately estimates assay sensitivity and specificity even when little or no information is provided in the prior distributions. We illustrate the performance of our estimation methods using simulation and by applying them to chlamydia and gonorrhea data collected in Nebraska. Copyright © 2016 John Wiley & Sons, Ltd.

Indexed as

Bayes TheoremEpidemiologic StudiesChlamydia InfectionsGonorrheaHumansMass ScreeningNebraskaPrevalenceBayesian estimationgroup testinginfertility prevention projectpooled testingscreeningsensitivityspecificity

Identifiers

PMID27090057
PMCPMC4965323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.